Results 41 to 50 of about 585,525 (398)

From Left Ventricular Hypertrophy to Dysfunction and Failure.

Circulation Journal, 2016
Left ventricular hypertrophy (LVH) is growth in left ventricular mass caused by increased cardiomyocyte size. LVH can be a physiological adaptation to strenuous physical exercise, as in athletes, or it can be a pathological condition, which is either ...
D. Lazzeroni, O. Rimoldi, P. Camici
semanticscholar   +1 more source

Geometric changes allow normal ejection fraction despite depressed myocardial shortening in hypertensive left ventricular hypertrophy [PDF]

, 1995
Objectives.This study of hypertensive left ventricular hypertrophy 1) assessed myocardial shortening in both the circumferential and long-axis planes, and 2) investigated the relation between geometry and systolic function.Background.In hypertensive left
Aurigemma, Gerard P., Gaasch, William H., Priest, Margaret A., Silver, Kevin H.   +3 more
core   +1 more source

Deletion of Interleukin-6 Attenuates Pressure Overload-Induced Left Ventricular Hypertrophy and Dysfunction.

Circulation Research, 2016
RATIONALE The role of interleukin (IL)-6 in the pathogenesis of cardiac myocyte hypertrophy remains controversial. OBJECTIVE To conclusively determine whether IL-6 signaling is essential for the development of pressure overload-induced left ventricular
Lin Zhao, Guangming Cheng, R. Jin, M. Afzal, A. Samanta, Y. Xuan, M. Girgis, Harold K Elias, Yanqing Zhu, Arash Davani, Yanjuan Yang, Xingdong Chen, Sheng Ye, O. Wang, Lei Chen, Jeryl Hauptman, Robert J. Vincent, B. Dawn   +17 more
semanticscholar   +1 more source

Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension.

American Society of Nephrology. Clinical Journal, 2016
BACKGROUND AND OBJECTIVES Left ventricular hypertrophy (LVH) and abnormal left ventricular (LV) geometry predict adverse outcomes in the general and hypertensive populations, but findings in CKD are still inconclusive.
E. Paoletti, L. De Nicola, F. Gabbai, P. Chiodini, M. Ravera, Laura Pieracci, Sonia Marre, P. Cassottana, Sergio Lucà, S. Vettoretti, S. Borrelli, G. Conte, R. Minutolo   +12 more
semanticscholar   +1 more source

Echocardiographic Evaluation of Left Ventricular Hypertrophy

Journal of the Indian Academy of Echocardiography & Cardiovascular Imaging
Left ventricular hypertrophy (LVH) can occur as a result of increase in the left ventricular (LV) wall thickness or increase in the LV cavity size, thus leading to increase in the LV mass. Strength training and aerobic exercise lead to physiological LVH,
Rajesh K. Shah
doaj   +1 more source

Comorbid CAD and Ventricular Hypertrophy Compromise The Perfusion of Myocardial Tissue at Subcritical Stenosis of Epicardial Coronaries [PDF]

, 2018
BACKGROUND: Most studies of CAD revascularization have been based on and reported according to angiographic criteria which don't consider the relation between the resulting effective flow distal to the stenosis and the demand of a hypertrophied myocardial tissue.
arxiv   +1 more source

Synthesis of standard 12-lead electrocardiograms using two dimensional generative adversarial network [PDF]

arXiv, 2021
This paper proposes a two-dimensional (2D) bidirectional long short-term memory generative adversarial network (GAN) to produce synthetic standard 12-lead ECGs corresponding to four types of signals: left ventricular hypertrophy (LVH), left branch bundle block (LBBB), acute myocardial infarction (ACUTMI), and Normal.
arxiv  

Electrocardiographic (ECG) criteria for determining left ventricular mass in young healthy men; data from the LARGE Heart study [PDF]

, 2009
Background: Doubts remain over the use of the ECG in identifying those with increased left ventricular (LV) mass. This is especially so in young individuals, despite their high prevalence of ECG criteria for LV hypertrophy.
Montgomery, HE, Payne, JR, Pennell, DJ, Shukla, R, Sohaib, SMA, World, M   +5 more
core   +2 more sources

Clinical implications of left atrial changes after optimization of medical therapy in patients with heart failure

European Journal of Heart Failure, Volume 24, Issue 11, Page 2131-2139, November 2022., 2022
Among patients with new‐onset or worsening heart failure (HF) undergoing optimization of HF medical therapy, dose up‐titration of angiotensin‐converting enzyme inhibitor/angiotensin receptor blocker (ACEi/ARB) therapy was associated with lower likelihood of left atrial adverse remodelling (LAAR).
Riccardo M. Inciardi, Matteo Pagnesi, Carlo M. Lombardi, Stefan D. Anker, John G. Cleland, Kenneth Dickstein, Gerasimos S. Filippatos, Chim C. Lang, Leong L. Ng, Pierpaolo Pellicori, Piotr Ponikowski, Nilesh J. Samani, Faiez Zannad, Dirk J. van Veldhuisen, Scott D. Solomon, Adriaan A. Voors, Marco Metra   +16 more
wiley   +1 more source

N-terminal proBrain Natriuretic Peptide as Indicator of Left Ventricle Hypertrophy In Hypertensive Patients Compared with Left Ventricle Mass Index in Echocardiography

Majalah Kardiologi Indonesia, 2013
Background: Some research reports the usefulness of the N-terminal proBrain natriuretic peptide (NT proBNP) as a diagnostic tool for left ven-tricular hypertrophy due to increased levels of NT proBNP in hypertensive patients with left ventricular ...
Mohammad Ariful Munir, Djanggan Sargowo
doaj   +1 more source